A 12-Week Safety and Pharmacodynamic Study of AT1001 in Female Patients With Fabry Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00304512
Recruitment Status : Completed
First Posted : March 20, 2006
Last Update Posted : January 16, 2018
Information provided by (Responsible Party):
Amicus Therapeutics